Clinical Trial Update: PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating prophylaxis of graft-versus-host disease in elderly patients undergoing haploidentical allogeneic hematopoietic stem cell tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Malignancy

Drugs mentioned

• Anti-lymphocyte serum (low-dose)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Hematological Malignancy | Phase 2 | Status: UNKNOWN